BBNX
HEALTHCAREBeta Bionics Inc
$10.57+0.56 (+5.59%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving BBNX Today?
No stock-specific AI insight has been generated for BBNX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$8.80$32.71
$10.57
Fundamentals
Market Cap$471M
P/E Ratio—
EPS$-1.37
Dividend Yield—
Dividend / Share—
ROE-0.2%
Profit Margin-0.6%
Debt / Equity—
Trading
Volume1.0M
Avg Volume (10D)—
Shares Outstanding44.6M
BBNX News
20 articles- Beta Bionics to Present at the Bank of America Securities Health Care ConferenceYahoo Finance·Apr 27, 2026
- Global Automated Insulin Delivery System Market Size/Share Worth USD 2684 Million by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)Yahoo Finance·Apr 23, 2026
- Beta Bionics, Inc. Q1 2026 Earnings Call SummaryMoby·Apr 22, 2026
- Beta Bionics Inc (BBNX) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amid Operational ...Yahoo Finance·Apr 22, 2026
- Beta Bionics Q1 Earnings Call HighlightsMarketbeat·Apr 21, 2026
- Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue EstimatesYahoo Finance·Apr 21, 2026
- Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 GuidanceYahoo Finance·Apr 21, 2026
- Beta Bionics, Inc. (BBNX) Soars 10.3%: Is Further Upside Left in the Stock?Yahoo Finance·Apr 16, 2026
- Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes CareYahoo Finance·Mar 31, 2026
- Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026Yahoo Finance·Mar 30, 2026
- Beta Bionics Details iLet Automation Strategy, Sales Expansion and Mint Patch Pump Timeline at ConferenceMarketbeat·Mar 6, 2026
- Senseonics launches automated insulin dosing system with 1-year CGMMedtechdive·Feb 20, 2026
- Beta Bionics to Present at the TD Cowen 46th Annual Health Care ConferenceYahoo Finance·Feb 19, 2026
- Sands Capital Opens $10 Million ServiceTitan PositionMotley Fool·Feb 18, 2026
- Beta Bionics, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 18, 2026
- Beta Bionics Inc (BBNX) Q4 2025 Earnings Call Highlights: Record Growth Amid Regulatory ChallengesYahoo Finance·Feb 18, 2026
- Beta Bionics Q4 Earnings Call HighlightsMarketbeat·Feb 18, 2026
- Beta Bionics (BBNX) Q4 2025 Earnings TranscriptMotley Fool·Feb 17, 2026
- Beta Bionics, Inc. (BBNX) Reports Q4 Loss, Tops Revenue EstimatesYahoo Finance·Feb 17, 2026
- Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026Yahoo Finance·Feb 17, 2026
All 20 articles loaded
Price Data
Open$10.24
Previous Close$10.01
Day High$10.54
Day Low$10.16
52 Week High$32.71
52 Week Low$8.80
52-Week Range
$8.80$32.71
$10.57
Fundamentals
Market Cap$471M
P/E Ratio—
EPS$-1.37
Dividend Yield—
Dividend / Share—
ROE-0.2%
Profit Margin-0.6%
Debt / Equity—
Trading
Volume1.0M
Avg Volume (10D)—
Shares Outstanding44.6M
About Beta Bionics Inc
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. The company is headquartered in Irvine, California.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—